#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebellar ataxia Stress cardiomyopathy Follicular lymphoma stage I ABO haemolytic disease of newborn Systemic candida Univentricular heart Cerebral haemorrhage Bronchiolitis Hepatitis D Progressive multifocal leukoencephalopathy Chemical burn Acquired C1 inhibitor deficiency Toxic epidermal necrolysis Cholangiocarcinoma Uveitis More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Trials in Disease Mantle cell lymphoma refractory – Treatment Mantle cell lymphoma stage III – Trials in Disease Mucopolysaccharidosis II Brain stem glioma – Diagnostics Bronchopulmonary dysplasia – Basic Information Epidermolysis bullosa Primary biliary cholangitis – Treatment Haemophilia B without inhibitors – Diagnostics Pulmonary sarcoidosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vilanterol Psilocybine Alfacalcidol Colistimethate Sodium Lisaftoclax Cibotercept Ponsegromab Rbl007.2 Crovalimab Simoctocog Alfa Ucp4 Cx-039776 Spiramycin Neob Mecasermin Rinfabate Mercaptamine Heterodimeric Interleukin-15 ZODASIRAN 1,3-BUTYLENE GLYCOL Prx005 More therapies…

    Learn about Your Condition

    Glomerulonephritis chronic Mast cell activation syndrome Chronic hepatic failure Thyroid cancer metastatic Lymphatic malformation Stress urinary incontinence Uveitis Epidermolysis bullosa Thrombocytopenia Metastatic glioma Medulloblastoma Peritonitis Arthralgia Bipolar I disorder Thrombectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Evaluation of Optimized Ceftazidime Dosing Regimen Versus Standard Treatment for Critical Care Patients with Sepsis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Ceftazidime
    France

  • Study of Reduced Cyclophosphamide Dose After Haploidentical Stem Cell Transplantation in Patients with Blood Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Cyclophosphamide
    France

  • Study on COR-1167 for Patients with Worsening Heart Failure

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Czechia Hungary Poland Romania Spain

  • Study of Platelet-Rich Plasma and Growth Factors Given by Ovarian Injection to Women with Low Ovarian Reserve During IVF Treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Platelet Concentrate
    • Sodium Chloride
    Spain

  • Evaluating Safety and Effectiveness of Combining Biologic Medications for Patients with Rheumatoid Arthritis and Psoriatic Arthritis ## Human: Give a detailed summary of a clinical trial for patients: 1.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tocilizumab
    Spain

  • Study on the Effectiveness and Safety of Extended vs. Intermittent Infusion of Meropenem in Critically Ill Children with Suspected or Proven Infection

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Meropenem Anhydrous
    • Meropenem Trihydrate
    • Ceftriaxone
    Hungary
Previous Page
1 … 796 797 798 799 800 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!